These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20207279)

  • 41. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection.
    Moise PA; Castro RS; Sul C; Forrest A; Sakoulas G
    Ann Pharmacother; 2008 Apr; 42(4):592-3. PubMed ID: 18349303
    [No Abstract]   [Full Text] [Related]  

  • 42. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B; Merckoll P; Melby KK
    Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
    Bassetti M; Di Biagio A; Del Bono V; Cenderello G; Bassetti D
    Int J Antimicrob Agents; 2004 Jul; 24(1):83-4. PubMed ID: 15225867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
    Mave V; Garcia-Diaz J; Islam T; Hasbun R
    J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.
    Mangili A; Bica I; Snydman DR; Hamer DH
    Clin Infect Dis; 2005 Apr; 40(7):1058-60. PubMed ID: 15825002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
    Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
    Gales AC; Sader HS; Andrade SS; Lutz L; Machado A; Barth AL
    Int J Antimicrob Agents; 2006 Apr; 27(4):300-2. PubMed ID: 16527459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Future strategies for treating Staphylococcus aureus bloodstream infections.
    Naber CK
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():26-34. PubMed ID: 18226087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comment on: linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
    De Beeck VO; Dhif N; Philipp J; De Bels D
    J Antimicrob Chemother; 2006 Mar; 57(3):577. PubMed ID: 16431858
    [No Abstract]   [Full Text] [Related]  

  • 50. Daptomycin for eradication of a systemic infection with a methicillin-resistant-Staphylococcus aureus in a biventricular assist device recipient.
    Weis F; Beiras-Fernandez A; Kaczmarek I; Sodian R; Vicol C; Reichart B; Weis M
    Ann Thorac Surg; 2007 Jul; 84(1):269-70. PubMed ID: 17588430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease.
    Kuo CC; Wu VC; Huang YT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2009 Jan; 33(1):96-8. PubMed ID: 18790610
    [No Abstract]   [Full Text] [Related]  

  • 52. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB; Ross T; Gregson DB
    J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Linezolid to decrease length of stay in the hospital for patients with methicillin-resistant Staphylococcus aureus infection.
    Siegel RE
    Clin Infect Dis; 2003 Jan; 36(1):124; author reply 124-5. PubMed ID: 12491215
    [No Abstract]   [Full Text] [Related]  

  • 54. Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).
    Bassetti M; Di Biagio A; Cenderello G; Del Bono V; Palermo A; Cruciani M; Bassetti D
    J Infect; 2001 Aug; 43(2):148-9. PubMed ID: 11676523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
    Itani KM; Weigelt J; Li JZ; Duttagupta S
    Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy.
    Tenover FC; Sinner SW; Segal RE; Huang V; Alexandre SS; McGowan JE; Weinstein MP
    Int J Antimicrob Agents; 2009 Jun; 33(6):564-8. PubMed ID: 19233622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Daptomycin cure after cefazolin treatment failure of Methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line.
    Cunha BA; Hamid N; Kessler H; Parchuri S
    Heart Lung; 2005; 34(6):442-7. PubMed ID: 16324966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
    Melzer M; Eykyn SJ; Gransden WR; Chinn S
    Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
    Lemaire S; Kosowska-Shick K; Julian K; Tulkens PM; Van Bambeke F; Appelbaum PC
    Clin Microbiol Infect; 2008 Aug; 14(8):766-77. PubMed ID: 18727801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.